ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 1 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $128,588 | -55.7% | 23,594 | -45.5% | 0.01% | -54.5% |
| Q2 2023 | $290,470 | +35.6% | 43,289 | +78.4% | 0.01% | +22.2% |
| Q1 2023 | $214,269 | -71.6% | 24,266 | -75.4% | 0.01% | -77.5% |
| Q4 2022 | $753,885 | +120.4% | 98,676 | +105.1% | 0.04% | +207.7% |
| Q3 2022 | $342,000 | -62.5% | 48,100 | -57.3% | 0.01% | -66.7% |
| Q2 2022 | $911,000 | -45.9% | 112,589 | -7.2% | 0.04% | -45.8% |
| Q1 2022 | $1,684,000 | +187.4% | 121,320 | +732.8% | 0.07% | +30.9% |
| Q1 2021 | $586,000 | – | 14,567 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $20,334,212 | 13.72% |
| BERYLSON CAPITAL PARTNERS, LLC | 228,000 | $1,529,880 | 4.32% |
| Eagle Health Investments LP | 1,214,860 | $8,151,711 | 1.52% |
| Matrix Capital Management Company, LP | 11,572,590 | $77,652,079 | 0.90% |
| Triatomic Management LP | 121,166 | $813,024 | 0.83% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $201,257,781 | 0.82% |
| Aristotle Atlantic Partners, LLC | 3,104,961 | $20,834,288 | 0.78% |
| Pier Capital, LLC | 737,589 | $4,949,222 | 0.71% |
| ARK Investment Management | 10,453,752 | $70,144,675 | 0.46% |
| Nikko Asset Management Americas, Inc. | 6,384,047 | $42,773,115 | 0.45% |